Results 151 to 160 of about 175,762 (228)

Soluble Urokinase Plasminogen Activator Receptor Predicts Survival and Hepatic Decompensation in Advanced Hepatocellular Carcinoma. [PDF]

Liver Int
Artusa F, Lamatsch S, Phan MD, Özdirik B, Berger H, Egerer M, Knorr-Klocke J, Fischer J, Veelken R, van Bömmel F, Berg T, Kappert K, Tauber R, Puengel T, Engelmann C, Demir M, Tacke F, Mohr R.   +17 more
europepmc   +1 more source

The Value of Soluble Urokinase Plasminogen Activator Receptor (suPAR) as Predictive Tool in Hospitalised Patients With Community-Acquired Pneumonia (CAP). [PDF]

Clin Respir J
Hessels L, Duijkers R, Schoorl M, Terpstra L, Thijs W, Boersma W.   +5 more
europepmc   +1 more source

Soluble urokinase plasminogen activator receptor promotes endoplasmic reticulum stress and apoptosis susceptibility through RAGE in sepsis acute kidney injury. [PDF]

Mol Med
Wang B, Wang J, Qi C, Gao C, Wang Y, Zan Y, Tan Y, Wu Z, Jiang J, Suo J, Zhang J, Peng Z.   +11 more
europepmc   +1 more source

Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic biomarker in acutely admitted patients with atrial fibrillation. [PDF]

J Arrhythm
Wisborg FD, El Caidi NO, Taraldsen IA, Tonning S, Kandiah A, El-Sheikh M, Bahrami HSZ, Andersen O, Rasmussen LJH, Hove J, Dixen U, Grand J.   +11 more
europepmc   +1 more source

Forskolin Enhances Urokinase Plasminogen Activator Secretion and Angiogenic Activity of Xeno-Free Cultures of Human Adipose Tissue-Derived Stem Cells. [PDF]

Adv Biol (Weinh)
Giraudo MV, Lauvrud AT, Wiberg R, Brohlin M, Andersson G, Kingham PJ.   +5 more
europepmc   +1 more source

Association of soluble urokinase plasminogen activator receptor and epidermal growth factor with histopathological findings of kidney biopsy: a single-center study. [PDF]

BMC Nephrol
Nagy E, Almenshawy A, Abdelsalam M, Elwahab AMA, Gharbia OM, El-Husseiny Moustafa F, Ahmed NS, Khreba NA.   +7 more
europepmc   +1 more source

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Predicts 28-Day and 90-Day Mortality in Emergency Department Patients with Chest Pain, Dyspnoea, or Abdominal Pain. [PDF]

Diagnostics (Basel)
Gavelli F, Giolitti FM, Vidali M, Montersino M, Bertoli M, Molinari L, Baldrighi M, Beltrame M, Sainaghi PP, Bellan M, Patrucco F, Avanzi GC, Castello LM.   +12 more
europepmc   +1 more source

Soluble urokinase plasminogen activator receptor for risk stratification from undifferentiated acute chest pain through to convalescence after acute coronary syndromes. [PDF]

Eur Heart J Open
Keys T, Greer C, Adamson PD, Pickering JW, Pilbrow AP, Frampton C, Hayek S, Troughton RW, Doughty RN, Richards AM, Pemberton CJ, Chew-Harris J.   +11 more
europepmc   +1 more source

Evaluation of Soluble Urokinase Plasminogen Activator Receptor in COVID-19 Patients. [PDF]

J Clin Med
Arientová S, Matúšková K, Bartoš O, Beran O, Holub M.   +4 more
europepmc   +1 more source

Soluble urokinase plasminogen activator receptor and interleukin-6 improves prediction of all-cause mortality and major adverse cardiovascular events in Type 1 diabetes. [PDF]

J Intern Med
Bahrami HSZ, Jørgensen PG, Hove JD, Dixen U, Rasmussen LJH, Eugen-Olsen J, Rossing P, Jensen MT.   +7 more
europepmc   +1 more source